Global Enzyme Replacement Therapy Market Outlook 2022

Global Enzyme Replacement Therapy Market Outlook 2022

  • QYResearch
  • January 2022
  • Medical Equipments
  • 111 pages

Report Description

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Injectable Agents
Oral Agents

Segment by Application
Gaucher Disease
Fabry Disease
MPS Disease
Gastrointestinal Disease
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Sanofi
Takeda
BioMarin
AbbVie
Alexion
Allergan
Horizon Pharma
Johnson & Johnson
Actelion
Recordati Rare Diseases
Pfizer
Digestive Care
Leadiant Biosciences

Have query on this report?

Make an Enquiry
1 Enzyme Replacement Therapy Market Overview
1.1 Product Overview and Scope of Enzyme Replacement Therapy
1.2 Enzyme Replacement Therapy Segment by Type
1.2.1 Global Enzyme Replacement Therapy Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Injectable Agents
List of Tables
Table 1. Global Enzyme Replacement Therapy Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Enzyme Replacement Therapy Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Enzyme Replacement Therapy Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Enzyme Replacement Therapy Covered in This Study
Table 5. Global Enzyme Replacement Therapy Sales (K Units) of Key Manufacturers (2016-2021)

Success Stories

Our Clients